Figure 3 | Scientific Reports

Figure 3

From: Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients

Figure 3

Concentrations of endogenous metabolic markers in the low-, medium, and high-AUC group. (A) C9:1 carnitine, (B) C12:1-OH carnitine, and (C) phenylacetylglutamine. (D) Relative intensity of deferoxamine in the low-, medium, and high-AUC group. *Jonckheere-Terpstra trend test (P < 0.05) and **Kruskal-Wallis test followed by Mann-Whitney tests (significance was adjusted by Bonferroni’s method, P < 0.017).

Back to article page